16th International AIDS Conference


Toronto, Canada - August 13 - 18, 2006


MODELING THE COST-EFFECTIVENESS OF RAPID POINT-OF-CARE DIAGNOSTIC TESTS FOR THE CONTROL OF HIV AND OTHER SEXUALLY TRANSMITTED INFECTIONS AMONGST FEMALE SEX WORKERS

Int Conf AIDS. 2006 Aug 13-18;16 Abstract No. TuAc0402

P. Vickerman1, C. Watts1, R. Peeling2, D. Mabey1, M. Alary3
1 LSHTM, London, United Kingdom, 2 WHO, Sexually Transmitted Diseases Diagnostics Initiative, Geneva, Switzerland, 3 Centre hospitalier affilié universitaire de Québec and Université Laval, Quebec, Canada


BACKGROUND: In sub-Saharan Africa, gonococcal and chlamydial infections are usually managed using the syndromic approach. However, many infections are asymptomatic in women, and the syndromic algorithm has poor sensitivity and specificity for infections caused by Neisseria gonorrhoea (Ng) and Chlamydia trachomatis (Ct) . Because of this, rapid point-of-care (POC) tests for Ct/Ng could improve STI management in women. This study uses mathematical modelling to estimate the incremental costeffectiveness of using POC tests to diagnose Ng/Ct instead of the current syndromic approach used by the SIDA2 HIV/STI prevention project for female sex workers in Cotonou, Benin.

METHODS: A dynamic mathematical model was used with data from Cotonou to estimate the HIV impact of the existing SIDA2 project (1995 – 1998), and to project how impact would change if POC tests had been used. As observed in test evaluations, the POC tests were assumed to have high specificity, but a range of sensitivities. The incremental economic cost-effectiveness of using POC tests was modelled using intervention cost data and data from an evaluation of a Ng POC test in Cotonou in 2004. All costs were in 2004US$.

RESULTS: The model estimated the STI treatment aspect of the intervention averted 18,553 Ng/Ct and 359 HIV infections over 4-years. In contrast, if Ng/Ct had been diagnosed with a 70 – 80% sensitive and 95% specific POC test then 24 – 31% less clinic attenders would have been treated, but 42 – 60% more HIV infections would have been averted. If these POC tests cost $1 – 2, the incremental cost-effectiveness of using them would be $58 – 152 per HIV infection averted.

CONCLUSIONS: POC tests can be a cost-effective strategy for substantially increasing the impact on HIV transmission, and decreasing the over-treatment of STI treatment interventions that use syndromic management to diagnose Ng/Ct.

Acrobat ReaderDownload PDF of this abstract.

Power Point PresentationDownload Power Point Presentation.

2006-08-13
TuAc0402


Copyright © 2006 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.